Mesenchymal stem cells: Weapons or dangers for cancer treatment?;Les cellules souches mésenchymateuses: Armes ou dangers pour le traitement des cancers?

Medecine/Sciences

Volumn 27, Issue 3, 2011, Pages 285-288

  Lazennec, Gwendal ^a,b  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW; TROPISM;

HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NEOPLASMS; TROPISM;

EID: 79955006802     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2011273285     Document Type: Review

References (33)

1. Lazennec G, Jorgensen C. Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 2008 ; 26:1387-94.
2. Wang H, Cao F, De A, et al. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 2009 ; 27 :1548-58.
3. Loebmger MR, Kyrtatos PG, Turmaine M, et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009 ; 69:8862-7.
4. Ho IA, Chan KY, Ng WH, et al. Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells 2009 ; 27 :1366-75.
5. Gutova M, Najbauer J, Frank RT, et al. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem Cells 2008 ; 26:1406-13.
6. Dwyer RM, Potter-Beirne SM, Harrington KA, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007 ; 13:5020-7. (Pubitemid 47502066)
7. Kim DS, Kim JH, Lee JK, et al. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev 2009;18:511-9.
8. Birnbaum T, Roider J, Schankin CJ, et al. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 2007 ; 83:241-7. (Pubitemid 46952234)
9. Feng B, Chen L. Review of mesenchymal stem cells and tumors: executioner or coconspirator? Cancer Biother Radiopharm 2009 ; 24 : 717-21.
10. Spaeth E, Klopp A, Dembinski J, et al. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008; 15: 730-8. (Pubitemid 351627356)
11. Kidd S, Spaeth E, Dembinski JL, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using m vivo bioluminescent imaging. Stem Cells 2009 ; 27: 2614-23.
12. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007 ; 449 : 557-63. (Pubitemid 47525152)
13. Makinoshima H, Dezawa M. Pancreatic cancer cells activate CCLS expression in mesenchymal stromal cells through the insulin-like growth factor-1 pathway. FEBS Lett 2009; 583: 3697-703.
14. Coffelt SB, Marim FC, Watson K, et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA 2009 ; 106 : 3806-11.
15. Spaeth EL, Dembinski JL, Sasser AK, et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009 ; 4 : e4992.
16. Sasser AK, Sullivan NJ, Studebaker AW, et al. Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. Faseb J 2007 ; 21: 3763-70. (Pubitemid 350075164)
17. Molloy AP, Martin FT, Dwyer RM, et al. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer 2009 ; 124 : 326-32.
18. Djouad F, Plence P, Bony C, et of. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 ; 102 : 3837-44. (Pubitemid 37409409)
19. Zhu Y, Sun Z, Han Q, et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 2009 ; 23 : 925-33.
20. Martin FT, Dwyer RM, Kelly J, et al. Potential role of mesenchymal stem cells (CSMs) in the breast tumour microenvironment. stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 2010 ; 124: 317-26.
21. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005 ; 121: 335-48. (Pubitemid 40692295)
22. Mishra PJ, Mishra PJ, Humeniuk R, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008 ; 68 :4331-9.
23. Vilalta M, Degano IR, Bago J, et al. Human adipose tissue-derived mesenchymal stromal cells as vehicles for tumor bystander effect: a model based on bioluminescence imaging. Gene Ther 2009 ; 16 : 547-57.
24. Kucerova L, Altanerova V, Matuskova M, et al. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy Cancer Res 2007;67:6304-13. (Pubitemid 47037513)
25. Loebinger MR, Eddaoudi A, Davies D, Janes SM. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res 2009 ; 69 : 4134-42.
26. Fritz V, Noel D, Bouquet C, et al. Antitumoral activity and osteogenic potential of hATF-expressmg mesenchymal stem cells in a murine model of osteolytic tumor. Stem Cells 2008 ; 26 : 2981-90.
27. Chen XC, Wang R, Zhao X, et al. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered CSMs. Carcinogenesis 2006 ; 27 : 2434-41. (Pubitemid 44884100)
28. Li X, Lu Y, Huang W, et al. In vitro effect of adenovirus-mediated human Gamma Interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia. Hematol Oncol 2006 ; 24 :151-8. (Pubitemid 44483909)
29. Komarova S, Kawakami Y, Stoff-Khalili MA, et al. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006 ; 5:755-66.
30. Walkley CR, Olsen GH, Dworkin S, et al. A microenvironment-induced myeloproliferative syndrome caused by retmoic acid receptor gamma deficiency. Cell 2007; 129:1097-110. (Pubitemid 46908696)
31. Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia Nature 2010 ; 464 : 852-7.
32. Menendez P, Catalina P, Rodriguez R, et al. Bone marrow mesenchymal stem cells from infants with MLL-AF4 acute leukemia harbor and express the MLL-AF4 fusion gene.; Exp Med 2009 ; 206 : 3131-41.
33. Roger M, Clavreul A, Menei P. Cellules stromales mésenchymateuses : vecteurs cellulaires de nanoparticules au sein de tumeurs céré brales. Med Sci (Paris) 2011;27:234-6.